| Code | 0599D | ||||||||||
| MA number | 15/0049/19-S | ||||||||||
| Product Form: | ung nas 1x3 g (tuba Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | InfectoPharm Arzneimittel und Consilium GmbH, Germany | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | tube Al | ||||||||||
| Route of admin.: | Nasal use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 26.02.2019 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| SPC: |
SPC_Mupina 20 mg/g_ung nas_02/2019_REG.docx
|
| PIL: |
PIL_Mupina 20 mg_g_ung nas_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 21.11.2023 |
